{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:10:53Z","timestamp":1784848253689,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017542","name":"beijing hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017542","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate early changes in the intraocular pressure (IOP) and macular microvascular structure in eyes with branch retinal vein occlusion (BRVO) treated with intravitreal Ranibizumab injection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study enrolled 30 patients (one eye per patient) who received intravitreal injections (IVI) of ranibizumab for macular edema secondary to BRVO. IOP were measured before, 30\u00a0min (min) and 1 month following IVI. Changes in macular microvascular structure were examined via assessment of foveal avascular zone (FAZ) parameters, vascular density (VD) of superficial vascular complex (SVC), and deep vascular complex (DVC) in whole macula, central fovea and parafovea area which were measured automatically by optical coherence tomography angiography (OCTA) on the same time as IOP examinations. Paired t test and Wilcoxon test were used to compare pre- and post-injection values. The correlation between IOP and OCTA findings was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IOP Measurements at 30\u00a0min post-IVI (17.91\u2009\u00b1\u20093.36 mmHg) increased significantly from baseline (15.07\u2009\u00b1\u20092.58 mmHg, p\u2009&lt;\u20090.001), then became similar with baseline after 1 month (15.00\u2009\u00b1\u20093.16 mmHg, p\u2009=\u20090.925). 30\u00a0min past the injection, the parameters of VD of the SCP significantly decreased in comparison to baseline, then became similar with baseline after one month, while there were no significant changes in other OCTA parameters, including parameters of VD of the DCP and the FAZ. At 1 month after IVI, in comparison to baseline, no significant changes were observed in all of the OCTA parameters (P\u2009&gt;\u20090.05). There were no significant correlations between IOP and OCTA findings no matter 30\u00a0min or 1 month post-IVI (P\u2009&gt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Transient IOP elevation and decreased superficial macular capillary perfusion density were detected 30\u00a0min post-IVI, however, no potential continual macular microvascular damage was suspected.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-023-02889-2","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:07:15Z","timestamp":1681790835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acute and subacute intraocular pressure and macular microvascular structure changes after intravitreal ranibizumab injection in eyes with branch retinal vein occlusion"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"2889_CR1","doi-asserted-by":"crossref","unstructured":"Rogers SL, McIntosh RL, Lim L et al. \u201cNatural history of branch retinal vein occlusion: an evidence-based systematic review, \u201cOphthalmology, vol. 117, no. 6, pp.1094\u20131101, 2010.","DOI":"10.1016\/j.ophtha.2010.01.058"},{"issue":"3","key":"2889_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/IAE.0000000000000843","volume":"36","author":"M Ho","year":"2016","unstructured":"Ho M, Liu DTL, Lam DSC, Jonas JB. Retinal vein occlusions, from basics to the latest treatment. Retina. 2016;36(3):432\u201348.","journal-title":"Retina"},{"issue":"3","key":"2889_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjophthalmol-2014-305041","volume":"99","author":"H Gerding","year":"2015","unstructured":"Gerding H, Mones J, Tadayoni R, Boscia F, Pearce I, Priglinger \u00b4S. Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel. Br J Ophthalmol. 2015;99(3):297\u2013304.","journal-title":"Br J Ophthalmol"},{"key":"2889_CR4","first-page":"18","volume":"31","author":"S Song","year":"2015","unstructured":"Song S, Yu X, Dai H. The efficacy of combination of intravitreal ranibizumab with triamcinolone or laser photocoagulation for macular edema secondary to branch retinal vein occlusion. Chin J Ocular Fundus Dis. 2015;31:18\u201321.","journal-title":"Chin J Ocular Fundus Dis"},{"key":"2889_CR5","doi-asserted-by":"crossref","unstructured":"Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. \u201cIntravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion,\u201dRetina, vol. 27, no. 4, pp.419\u2013425,2007.","DOI":"10.1097\/IAE.0b013e318030e77e"},{"issue":"6","key":"2889_CR6","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","volume":"117","author":"PA Campochiaro","year":"2010","unstructured":"Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: sixmonth primary end point results of a phase III study. Ophthalmology. 2010;117(6):1102\u201312.","journal-title":"Ophthalmology"},{"issue":"3","key":"2889_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology. 2015;122(3):538\u201344.","journal-title":"Ophthalmology"},{"issue":"4","key":"2889_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.5301\/ejo.5000081","volume":"22","author":"SW Hong","year":"2012","unstructured":"Hong SW, Jee D. Effect of the Honan intraocular pressure reducer to prevent vitreous reflux after intravitreal bevacizumab injection. Eur J Ophthalmol. 2012;22(4):615\u20139.","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"2889_CR9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/eye.2014.180","volume":"28","author":"CD Murray","year":"2014","unstructured":"Murray CD, Wood D, Allgar V, et al. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. Eye (Lond). 2014;28(10):1218\u201322.","journal-title":"Eye (Lond)"},{"issue":"6","key":"2889_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s10384-011-0088-1","volume":"55","author":"KS Kim","year":"2011","unstructured":"Kim KS, Jee D. Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique. Jpn J Ophthalmol. 2011;55(6):632\u20137.","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"2889_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1097\/IAE.0000000000000476","volume":"35","author":"CE Pang","year":"2015","unstructured":"Pang CE, Mrejen S, Hoang QV, et al. Association between needle size, postinjection reflux, and intraocular pressure spikes after intravitreal injections. Retina. 2015;35(7):1401\u20136.","journal-title":"Retina"},{"issue":"1","key":"2889_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10384-012-0194-8","volume":"57","author":"A Cacciamani","year":"2013","unstructured":"Cacciamani A, Oddone F, Parravano, et al. Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length. \u201dJpn J Ophthalmol. 2013;57(1):63\u20137.","journal-title":"\u201dJpn J Ophthalmol"},{"key":"2889_CR13","doi-asserted-by":"crossref","unstructured":"Lisa T, Federica E, Pasquale V et al. \u201c Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy,\u201d Biomed Res Int, vol. 2020, 9496242,2020.","DOI":"10.1155\/2020\/9496242"},{"key":"2889_CR14","doi-asserted-by":"crossref","unstructured":"Chui Ming Gemmy Cheung. Kelvin Yi Chong Teo, Sai Bo Bo Tun, \u201cDifferential reperfusion patterns in retinal vascularplexuses following increase in intraocular pressure an oct angiography study,\u201d Sci. Rep, vol.\u00a010, no.1, pp.\u00a016505, 2020.","DOI":"10.1038\/s41598-020-73585-0"},{"issue":"4","key":"2889_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/IAE.0000000000002433","volume":"40","author":"A Barash","year":"2020","unstructured":"Barash A, Chui TYP, Garcia P, Rosen RB. Acute macular and peripapillary angiographic changes with intravitreal injections. Retina. 2020;40(4):648\u201356.","journal-title":"Retina"},{"issue":"1","key":"2889_CR16","doi-asserted-by":"publisher","first-page":"19381","DOI":"10.1038\/s41598-021-98850-8","volume":"11","author":"MRobertJ Nadhini Arumuganathan","year":"2021","unstructured":"Nadhini Arumuganathan MRobertJ, Wiest M, DamianoToro, et al. Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow postintravitreal injections. Sci Rep. 2021;11(1):19381.","journal-title":"Sci Rep"},{"key":"2889_CR17","doi-asserted-by":"crossref","unstructured":"Shuang Song X, Yu P, Zhang et al. \u201c Changes in Macular Microvascular Structure in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Antivascular Endothelial Growth Factor for One Year,\u201dJ Ophthalmol, May 17, 6645452,2021.","DOI":"10.1155\/2021\/6645452"},{"issue":"3","key":"2889_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1755-3768.2010.01904.x","volume":"90","author":"MM Knip","year":"2012","unstructured":"Knip MM, V\u00e4lim\u00e4ki J. Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study. Acta Ophthalmol. 2012;90(3):254\u20138.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"2889_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0029-1245201","volume":"227","author":"PE Theoulakis","year":"2010","unstructured":"Theoulakis PE, Lepidas J, Petropoulos IK, et al. Effect of brimonidine\/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monbl Augenheilkd. 2010;227(4):280\u20134.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"7","key":"2889_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/ceo.12311","volume":"42","author":"AS Gado","year":"2014","unstructured":"Gado AS, Macky TA. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison. Clin Exp Ophthalmol. 2014;42(7):650\u20135.","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"2889_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3109\/02713683.2014.888452","volume":"39","author":"M G\u00fcler","year":"2014","unstructured":"G\u00fcler M, Capkin M, Simsek A, et al. Short-term effects of intravitreal bevacizumab on cornea and anterior chamber. Curr Eye Res. 2014;39(10):989\u201393.","journal-title":"Curr Eye Res"},{"issue":"11","key":"2889_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.ophtha.2017.06.002","volume":"124","author":"HL Takusagawa","year":"2017","unstructured":"Takusagawa HL, Liu L, Ma KN. Projection-resolved Optical Coherence Tomography Angiography of Macular Retinal circulation in Glaucoma. Ophthalmology. 2017;124(11):1589\u201399.","journal-title":"Ophthalmology"},{"issue":"4","key":"2889_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1523\/JNEUROSCI.12-04-01169.1992","volume":"12","author":"DM Snodderly","year":"1992","unstructured":"Snodderly DM, Weinhaus RS, Choi JC. Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis). J Neurosci. 1992;12(4):1169\u201393.","journal-title":"J Neurosci"},{"issue":"1","key":"2889_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cne.902970111","volume":"297","author":"DM Snodderly","year":"1990","unstructured":"Snodderly DM, Weinhaus RS. Retinal vasculature of the fovea of the squirrel monkey, Saimiri sciureus: three-dimensional architecture, visual screening, and relationships to the neuronal layers. J Comp Neurol. 1990;297(1):145\u201363.","journal-title":"J Comp Neurol"},{"issue":"6","key":"2889_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S1350-9462(01)00012-X","volume":"20","author":"JM Provis","year":"2001","unstructured":"Provis JM. Development of the primate retinal vasculature. Prog Retin Eye Res. 2001;20(6):799\u2013821.","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"2889_CR26","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/j.ophtha.2009.05.025","volume":"116","author":"O Tan","year":"2009","unstructured":"Tan O, Chopra V, Lu AT, et al. Detection of macular ganglion cell loss in glaucoma by Fourier domain optical coherence tomography. Ophthalmology. 2009;116(12):2305\u201314.","journal-title":"Ophthalmology"},{"issue":"6","key":"2889_CR27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ophtha.2011.12.014","volume":"119","author":"JC Mwanza","year":"2012","unstructured":"Mwanza JC, Durbin MK, Budenz DL, et al. Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology. 2012;119(6):1151\u20138.","journal-title":"Ophthalmology"},{"issue":"5","key":"2889_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0002-9394(89)90488-1","volume":"107","author":"HA Quigley","year":"1989","unstructured":"Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107(5):453\u201364.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2889_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cne.903000103","volume":"300","author":"CA Curcio","year":"1990","unstructured":"Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300(1):5\u201325.","journal-title":"J Comp Neurol"},{"issue":"1","key":"2889_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.16-20579","volume":"58","author":"K Ghasemi Falavarjani","year":"2017","unstructured":"Ghasemi Falavarjani K, Iafe NA, Hubschman JP, Tsui I, Sadda SR, Sarraf D. Optical coherence tomography angiography analysis of the Foveal Avascular Zone and Macular Vessel Density after Anti-VEGF therapy in eyes with Diabetic Macular Edema and retinal vein occlusion. Invest Ophthalmol Vis Sci. 2017;58(1):30\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"2889_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/IJG.0b013e3182948476","volume":"23","author":"BY Katayama","year":"2014","unstructured":"Katayama BY, Bonini-Filho MA, Messias AM, et al. Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial. J Glaucoma. 2014;23(7):461\u20133.","journal-title":"J Glaucoma"},{"issue":"5","key":"2889_CR32","first-page":"432","volume":"34","author":"Z Song Shuang","year":"2018","unstructured":"Song Shuang Z, Peng Gu, Xiaoya, et al. Analysis of factors associated with short-term elevation of intraocular pressure after ranibizumab intravitreal injection. Chin J Ocul Fundus Dis. 2018;34(5):432\u20135.","journal-title":"Chin J Ocul Fundus Dis"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-02889-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:08:15Z","timestamp":1681790895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-02889-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-02889-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2528811\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study approved by the Ethics Committee of Beijing Hospital, carried out in accordance with the tenets of the Declaration of Helsinki. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}